Screening compound: FKSNQNMQMZIZLE-UHFFFAOYSA-N

Screening compound: FKSNQNMQMZIZLE-UHFFFAOYSA-N
Screening compound: FKSNQNMQMZIZLE-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
FKSNQNMQMZIZLE-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T634-0898

Molecular Formula

C23H26N4O3S (C23 H26 N4 O3 S)

Compound Name

4-[(1-methyl-1H-imidazol-4-yl)sulfonyl]-7-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine

IUPAC name

4-[(1-methyl-1H-imidazol-4-yl)sulfonyl]-7-[(1234-tetrahydroisoquinolin-2-yl)methyl]-2345-tetrahydro-14-benzoxazepine

SMILES

Cn1cnc(S(N2Cc(cc(CN(CC3)Cc4c3cccc4)cc3)c3OCC2)(=O)=O)c1

InChI

InChI=1S/C23H26N4O3S/c1-25-16-23(24-17-25)31(28,29)27-10-11-30-22-7-6-18(12-21(22)15-27)13-26-9-8-19-4-2-3-5-20(19)14-26/h2-7,12,16-17H,8-11,13-15H2,1H3

InChI Key

FKSNQNMQMZIZLE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29010028

FKSNQNMQMZIZLE-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PI3K-Targeted Library (17255 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Epigenetic
  • PPI modulators
Targets:
  • GPCR
  • Ion Channels
  • Kinases
  • Others
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with FKSNQNMQMZIZLE-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound FKSNQNMQMZIZLE-UHFFFAOYSA-N?
Check Price and Availability of FKSNQNMQMZIZLE-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of FKSNQNMQMZIZLE-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for FKSNQNMQMZIZLE-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for FKSNQNMQMZIZLE-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of FKSNQNMQMZIZLE-UHFFFAOYSA-N available by request